Western blot analysis showed a decrease in FOXO3A phosphorylation in tumors treated with AMD3100 alone, suggesting that enhanced tumor regression upon treatment with AMD3100 is mediated by inhibition of the PTEN/PI3K/AKT pathway (Figure 7D). The gene discussed is PTEN; the disease is neoplasm.